Use of high-flow nasal cannula oxygen and risk factors for high-flow nasal cannula oxygen failure in critically-ill patients with COVID-19

BACKGROUND: High-flow nasal oxygen therapy (HFNC) may be an attractive first-line ventilatory support in COVID-19 patients. However, HNFC use for the management of COVID-19 patients and risk factors for HFNC failure remain to be determined. METHODS: In this retrospective study, we included all conse...

Descripción completa

Detalles Bibliográficos
Autores principales: Ait Hamou, Zakaria, Levy, Nathan, Charpentier, Julien, Mira, Jean-Paul, Jamme, Matthieu, Jozwiak, Mathieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719644/
https://www.ncbi.nlm.nih.gov/pubmed/36463161
http://dx.doi.org/10.1186/s12931-022-02231-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719644/
https://www.ncbi.nlm.nih.gov/pubmed/36463161
http://dx.doi.org/10.1186/s12931-022-02231-2

Ejemplares similares